Please login to the form below
CRO
This page shows the latest CRO news and features for those working in and with pharma, biotech and healthcare.
MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
Back in 2015, MSD said it was in discussions with an unnamed contract research organisation (CRO) about a possible sale that never came through, and this week it reiterated its hope
Latest news
-
Syneos Health announces partnership with AiCure
Syneos Health’s scale as a leading global CRO, and the largest contract commercial organisation, will enable valuable customer engagements and expands our reach with biopharmaceutical companies of all sizes,”
-
Skills shortage and Brexit will hit R&D, warns UK pharma
The survey of 56 respondents across 30 different pharma and CRO companies, which revealed concerned about a shortfall in candidates across STEM subjects, but especially in a number of key
-
AI specialist Exscientia buys Kinetic Discovery
Kinetic operates mainly as a contract research organisation (CRO) at present, providing services such as hit identification, confirmation and validation.
-
Geron poleaxed as partner J&J abandons only pipeline drug
He also noted that the company has hired a contract research organisation (CRO) to help ensure IMerge and an extended IMbark trial can continue without interruption.
-
New industry standards group launched
Henry Levy, president of Align Clinical CRO, said: “There’s tremendous potential to enhance clinical trial execution through common technology standards that will benefit the entire industry. ... Align Clinical CRO represents an important industry
Syneos Health announces partnership with AiCure
Skills shortage and Brexit will hit R&D, warns UK pharma
AI specialist Exscientia buys Kinetic Discovery
Geron poleaxed as partner J&J abandons only pipeline drug
New industry standards group launched
More from news
Approximately 34 fully matching, plus 70 partially matching documents found.
Latest Intelligence
-
How early-stage clinical research is facilitating the new wave of personalised medicines
Designing studies for gene therapies is not simply ‘business as usual’ for contract research organisations (CRO) and clinical investigators.
-
The lessons learned from COVID-19’s impact on oncology trials
Dave Espenshade is Vice President of CRO Partnerships, Greenphire. 25th May 2021.
-
Transforming clinical trial data into a long-term asset
of CRO respondents admitted to being unable to convert documents from multiple eClinical applications used in the course of a trial.
-
The important role of CROs in shaping the future of clinical research across Europe
Clinical Research Organisation (CRO) partners can assist in facilitating this, with access to sponsors, sites, investigators and patients.
-
Assessing the value of interim analyses in clinical trials
on all involved, from the sponsor as well as partners like the clinical research operation (CRO), to carefully decide whether an interim analysis is appropriate in the specific setting.
How early-stage clinical research is facilitating the new wave of personalised medicines
The lessons learned from COVID-19’s impact on oncology trials
Transforming clinical trial data into a long-term asset
The important role of CROs in shaping the future of clinical research across Europe
Assessing the value of interim analyses in clinical trials
More from intelligence
Approximately 1 fully matching, plus 15 partially matching documents found.
Latest appointments
-
New faces at creative digital agency earthware
Prior to joining earthware, Charles held responsibility for the marketing activities at Domainex, a drug-discovery CRO.
-
Metrion Biosciences adds to its board
Barry’s substantial experience of drug discovery deal-making will be of great value to Metrion as we continue to build our worldwide CRO and collaboration business, and Andy’s dedication
-
Lynn Lewis joins Envigo
She becomes the CRO’s senior vice president of global sales. Envigo, a contract research organisation, has appointed Lynn Lewis to the position of senior vice president of global sales, a
-
Remi Gauchoux joins Carenity
Gauchoux has a 20-year international experience in healthcare and the CRO industries with expertise in late phase and real-world evidence analysis. ... His career has seen him work for Mapi Group, where he held the role of senior director in global
-
Dr Martine Dehlinger-Kremer becomes EUCROF president
Dr Dehlinger-Kremer has over 30 years of clinical research industry experience and currently serves as vice president for global medical and regulatory affairs at San Diego, US-based CRO SynteractHCR.
New faces at creative digital agency earthware
Metrion Biosciences adds to its board
Lynn Lewis joins Envigo
Remi Gauchoux joins Carenity
Dr Martine Dehlinger-Kremer becomes EUCROF president
More from appointments
Approximately 12 fully matching, plus 54 partially matching documents found.
Latest from PMHub
-
Genetic Digital
Solutions for:. Pharmaceutical, biotech &CRO/CRM firms. Medical device manufacturers. Private healthcare providers.
-
Healthcare tech: the driving force behind value-based care?
Pharmaceutical companies and contract research organizations (CRO) are now adopting this platform technology at a lightning pace.
-
Carenity - ELSE CARE SAS
ELSE CARE SAS is digital CRO that could generate patients' insights through its direct-access to patient platform Carenity, allowing Real World Evidence generation for non interventional study at each step
-
Are patient recruitment and retention rates rising or falling?
The Tufts Center for the Study of Drug Development (CSDD) collected data on 87 clinical trials from four top-20 pharma companies and one global CRO, comparing the 2019 metrics from
-
Patients as partners: The future of clinical trial design?
Many employees of CRO companies believe that if the patient was to be involved in key decision-making stages, projects would be a lot more expensive and time consuming.
Genetic Digital
Are patient recruitment and retention rates rising or falling?
More from PMHub
Approximately 1 fully matching, plus 28 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Senior Account Manager
-
Competitive salary offered
-
Omnichannel Strategy Consultant
-
Competitive Salary
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Results of AstraZeneca’s TACKLE phase 3 trial show antibody combination reduces risk of severe COVID-19 or death
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Data shows patients treated with Biogen's MS therapies mount an effective antibody response to COVID-19 vaccination
- US demand for COVID-19 antibody treatments rising fast
- Assessing the value of interim analyses in clinical trials
- AstraZeneca chooses Ireland for $360m manufacturing site
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
- Breaking the silence: It’s time to talk about the menopause
- FDA accepts Regeneron’s REGEN-COV for priority review for treatment of COVID-19
- New data shows Roche's Enspryng significantly reduces neuromyelitis optica spectrum disorder relapses
- Beyond yoga and smoothies – providing real support for employee well-being
- Driving Healthcare Decisions with Natural Language Processing
- Results of AstraZeneca’s TACKLE phase 3 trial show antibody combination reduces risk of severe COVID-19 or death
- Novo Nordisk settles US insulin pricing dispute for $100m
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Onyx Health appoints Dean Forbes
- Sandoz completes acquisition of GSK’s cephalosporin business
- Public is more comfortable with health data sharing if they know it is to support breakthrough treatments and vaccines
PMHub
Viseven
Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...
Latest intelligence
- Breaking the silence: It’s time to talk about the menopause
- Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
- Committing time to making meaningful connections - top 5 tips
- Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
- News:
- Senior Analytics Specialist joins Research Partnership...
